Evidence mapPaperPMID 41751968Full record

ReviewInternational journal of molecular sciences2026

Curcumin as a Multi-Target Bioactive Molecule: Mechanistic Insights and Translational Perspectives.

Yuanzi Huang, Lu Liu, Shaoying Wu, Kaiying Wang, Li Li, Qijiang Shu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Effects of dietary nanocurcumin on growth, immunity and stress response in European seabass (Dicentrarchus labrax).Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanzi HuangInstitute of Information, Yunnan University of Chinese Medicine, Kunming 650500, China.ORCID 0009-0007-6899-9120
Lu LiuInstitute of Information, Yunnan University of Chinese Medicine, Kunming 650500, China.
Shaoying WuInstitute of Information, Yunnan University of Chinese Medicine, Kunming 650500, China.
Kaiying WangInstitute of Information, Yunnan University of Chinese Medicine, Kunming 650500, China.
Li LiKey Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Gastrointestinal Diseases, Yunnan Provincial Department of Education, Kunming 650500, China.
Qijiang ShuInstitute of Information, Yunnan University of Chinese Medicine, Kunming 650500, China.ORCID 0000-0003-2038-5406

Funding

2024 Innovative and Entrepreneurial Training Program for Undergraduates 405701028162024 Innovative and Entrepreneurial Training Program for Undergraduates 40570102817National Natural Science Foundation of China 82460988Open Subject of Yunnan Key Laboratory of Dai and Yi Medicines 2024JS2406Yunnan Province Basic Research Project 202501AT070335Yunnan Province TCM Joint Project 202301AZ070001-033
6 · The paper itself

Abstract

Curcumin, a natural polyphenolic compound derived from the curcuma genus, has attracted considerable attention due to its simple chemical structure, favorable safety profile, and broad-spectrum pharmacological activities. This review provides a comprehensive summary of recent advances in curcumin research, with a specific focus on its therapeutic potential in cancer, inflammation, depression, and metabolic disorders, including non-alcoholic fatty liver disease, hypertension, and osteoporosis. It highlights curcumin's modulation of critical signaling pathways, such as PI3K/Akt, NF-κB, JAK/STAT, MAPK/ERK, mTOR, and Wnt/β-catenin, which regulate essential cellular processes, including proliferation, apoptosis, metabolism, and immune response. In various models of solid tumors and hematologic malignancies, curcumin has exhibited potent anti-cancer effects and shows promise in combination with chemotherapy to overcome drug resistance. Moreover, the mechanisms underlying curcumin's effects on inflammation-related diseases and chronic conditions are becoming increasingly well-understood. To address its limitations, such as poor water solubility, rapid metabolism, and low bioavailability, several advanced drug delivery systems-such as nanocarriers, microspheres, and solid dispersions-have been developed to enhance its in vivo stability and targeting efficiency. Beyond its pharmacological applications, curcumin is also employed as a functional additive in food science, particularly in active packaging and food safety testing. In conclusion, curcumin not only serves as a valuable pharmacological probe but also functions as a natural molecular template bridging basic research, formulation innovation, and multidisciplinary translational applications. Future research should focus on optimizing its chemical structure, advancing biosynthesis engineering, and conducting rigorous clinical trials to facilitate its widespread adoption in precision medicine and health interventions.

Indexed as

CurcuminAnimalsAntineoplastic AgentsHumansInflammationNeoplasmsSignal TransductionAntineoplastic AgentsCurcuminanti-tumorcurcuminfunctional foodinflammation regulationmulti-target mechanism

Identifiers

PMID41751968
PMCPMC12941169

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.